EUVIMED · CrossrefZeitschrift
Cancer Communications
ISSN 2523-3548 · American Association for the Advancement of Science (AAAS)
Neueste Artikel
Gastric cancer burden in the Republic of Korea from 1990 to 2021: screening versus declining Helicobacter pylori prevalence
Prophylactic Cervical Lymphadenectomy Offers No Survival Benefit in the Surgical Management of Thoracic Esophageal Cancer: 10-Year Results of the ECTOP-2002 Randomized Controlled Trial
Association of Depth of Response with Survival After Immune Checkpoint Blockade in Advanced Melanoma
A Neural-Related Transcriptional Signature Is Associated with Reduced Immune Activity and Pathological Response to Neoadjuvant Chemo-Immunotherapy in Non-Small Cell Lung Cancer
The USP28/TFAP2A/MYC/SLC7A11 axis facilitates tumorigenesis by modulating ferroptosis and serves as a nanotherapeutic target in gemcitabine-resistant bladder cancer
Unraveling the Shaping of the Microenvironment in Brain Metastasis: From Dissemination to Overt Lesions
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLST
CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells
CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma
Harnessing the Power of CAR-NK Cells for Solid Tumors: Challenges, Innovations, and Future Frontiers in Immunotherapy
Erratum to “BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma”
Leveraging Innate Immune and Metabolic Cell Death Pathways in Cancer Therapies
Combined Immunotherapy and Hybrid Dose-Fraction Radiotherapy for Driver-Negative Metastatic NSCLC: A Phase II Trial with Parallel Preclinical Studies
Dirozalkib versus Crizotinib in Advanced Anaplastic Lymphoma Kinase Inhibitor-Naïve ALK -Positive Non-Small-Cell Lung Cancer: A Multicenter, Randomized Phase III Trial
Hypoxia-Induced Osteopontin-Positive Glioma-Associated Macrophages Facilitate Glioma Mesenchymal Transition via NF-κB Pathway Activation
Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles
Pan‐cyclin‐dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression
Anbenitamab in combination with chemotherapy in patients with HER2‐positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC‐WISE 01)
Harnessing chimeric antigen receptor macrophages against solid tumors
Lactylation in cancer biology: Unlocking new avenues for research and therapy
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials
Mechanism and role of regulated cell death in tumor immunity and immunotherapy
Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy
CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer
Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications
Coordinated gene expression within sustained STAT3‐associated chromatin conformations contributes to hepatocellular carcinoma progression
Ubiquitination in cancer: mechanisms and therapeutic opportunities
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial
EUVIMED